Updates from The Motley Fool

Latest updates on United Therapeutics Corp from Fool.com.


Stock Performance

UTHR vs. S&P 500 | 2 Year Performance
UTHR 1-Day Stock Chart
UTHR 5-Day Stock Chart
UTHR 1-Month Stock Chart
UTHR 3-Month Stock Chart
UTHR 6-Month Stock Chart
UTHR 1-Year Stock Chart
UTHR 2-Year Stock Chart
UTHR 5-Year Stock Chart
View Interactive UTHR Charts
Sponsored by

Key Data Points

Primary metrics and data points about United Therapeutics Corp.
Current Price: $108.20
Prev Close: $110.55
Open: $110.36
Bid: $108.03
Ask: $110.07
Day's Range: $107.77 - $111.23
52wk Range: $102.50 - $190.13
Volume: 788,626
Avg Vol 883,636
Market Cap: $4.94B
P/E (ttm): 8.69
EPS (ttm): $12.72
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about United Therapeutics Corp.
CAPS Rating 4 out of 5
 
260 Outperform
16 Underperform
CAPS All Stars
 
70 Outperform
4 Underperform

How do you think United Therapeutics Corp will perform against the market?



You pick for United Therapeutics Corp is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Martine A. Rothblatt, CEO

100% Approve

Based on 25 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for United Therapeutics Corp.

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers